Psychological aspects of motor neurone disease: A review

Clinical Rehabilitation

Volumn 10, Issue 3, 1996, Pages 185-194

  Worthington, Andrew ^a,b  

^a Rayners Hedge Rehabilitation Centre   (United Kingdom)

^b UNIVERSITY OF SURREY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CAREGIVER; COGNITIVE DEFECT; DEMENTIA; DISTRESS SYNDROME; EMOTION; FRONTAL LOBE; HUMAN; MOTOR NEURON DISEASE; PSYCHOLOGICAL ASPECT; PSYCHOMETRY; REVIEW; TRAINING;

EID: 0030002297     PISSN: 02692155     EISSN: None     Source Type: Journal    
DOI: 10.1177/026921559601000302     Document Type: Review

References (112)

1. Norris F, Shepherd R, Denys E et al. Onset, natural history and outcome in idiopathic adult motor neuron disease. J Neurol Sci 1993; 118: 48-55.
2. Williams DB, Floate DA, Leicester J. Familial motor neuron disease: differing penetrance in large pedigrees. J Neurol Sci 1988; 86: 215-30.
3. Tandan R, Bradley WG. Amyotrophic lateral sclerosis: part 1. Clinical features, pathology and ethical issues in management. Ann Neurol 1985; 18: 271-80.
4. Martin JE, Swash M, Schwartz MS. New insights into motor neuron disease. Neuropathol Appl Neurobiol 1990; 16: 97-110.
5. Armon C, Kurland LT, Smith GE, Steele JC. Sporadic and Western Pacific amyotrophic lateral sclerosis: epidemiological implications. In: Smith RA ed. Handbook of amyotrophic lateral sclerosis. New York: Marcel Dekker Inc., 1992: 93-131.
6. Kondo K. Epidemiology of motor neurone disease: ageing and exhaustion hypotheses re-visited. In: Rose FC ed. Research progress in motor neuron disease. London: Pitman, 1984: 20-33.
7. Mulder DW, Kurland LT. Motor neurone disease: epidemiological studies. In: Cosi V, Kato AC, Parlette W, Pinelli P, Poloni M eds. Amyotrophic lateral sclerosis: therapeutic, psychological and research aspects. New York: Plenum Press, 1987: 325-37.
8. Kurtzke JF. Epidemiology of amyotrophic lateral sclerosis. Adv Neurol 1982; 36: 281-302.
9. Lopez-Vega JM, Culleja J, Combarros O, Polo J, Berciano J. Motor neuron disease in Cantabria. Acta Neurol Scand 1988; 77: 1-5.
10. Steele JC, Guzman T. Observations about amyotrophic lateral sclerosis and the Parkinsonism-dementia complex of guam with respect to epidemiology and etiology. Can J Neurol Sci 1987; 14: 358-62.
11. Munsat T, Andres P, Finison L, Conlon T, Thibodeau L. The natural history of motor neuron loss in amyotrophic lateral sclerosis. Neurology 1988; 38: 409-13.
12. Christensen PB, Hojer-Pederson E, Jensen NB. Survival of patients with amyotrophic lateral sclerosis in two Danish counties. Neurology 1990; 40: 600-604.
13. Mitsuyama Y. Presenile dementia with motor neuron disease in Japan: clinico-pathological review of 26 cases. J Neurol Neurosurg Psychiatry 1984; 47: 953-59.
14. Drachman DB, Kund RW. Amyotrophic lateral sclerosis: an unconventional autoimmune disease? Ann Neurol 1989; 26: 269-74.
15. Leigh PN. Amyotrophic lateral sclerosis and other motor neurone diseases. Curr Opin Neurol Neurosurg 1990; 3: 567-75.
16. Goonetilleke A. Current therapies in motor neurone disease. Br J Hosp Med 1995; 53: 314-17.
17. Smith MC. Nerve fibre degeneration in the brain in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 1960; 23: 269-82.
18. Brownell B, Oppenheimer DR, Hughes JT. The central nervous system in motor neurone disease. J Neurol Neurosurg Psychiatry 1970; 33: 338-57.
19. Nakanishi T, Tamaki M, Arasaki K. Maximal and minimal nerve conduction velocities in amyotrophic lateral sclerosis. Neurology 1989; 39: 580-83.
20. Whitehouse P, Wamsley J, Zarbin M, Price D, Tourtellote W, Kuhar M. Amyotrophic lateral sclerosis: alterations in neurotransmitter receptors. Ann Neurol 1983; 14: 8-16.
21. Pamphlett R, Kril J, Hng TM. Motor neuron disease: a primary disorder of corticomotoneurons? Muscle Nerve 1995; 18: 314-18.
22. Rapport M, Donnenfeld H, Brunner W, Hungund B, Bartfeld H. Ganglioside patterns in amyotrophic lateral sclerosis brain regions. Ann Neurol 1985; 18: 60-67.
23. Toghi H, Tsukagoshi H, Toyokura Y. Quantitative changes of sural nerves in various neurological diseases. Acta Neuropathol 1977; 38: 95-101.
24. Bradley WG, Good B, Rasool C, Adelman L. Morphometric and biochemical studies of peripheral nerves in amyotrophic lateral sclerosis. Ann Neurol 1983; 14: 267-77.
25. Averback P, Crocker P. Regular involvement of Clarke's nucleus in sporadic amyotrophic lateral sclerosis. Arch Neurol 1982; 39: 155-56.
26. Kawamura Y, Dyck PJ, Shimono M, Okuzaki H, Tateishi J, Doi H. Morphometric comparison of the vulnerability of peripheral motor and sensory neuron in amyotrophic lateral sclerosis. J Neuropathol Exp Neurol 1981; 40: 667-75.
27. Heads T, Pollock M, Robertson A, Sutherland W, Allpress S. Sensory nerve pathology in amyotrophic lateral sclerosis. Acta Pathol 1991; 82: 316-20.
28. Li TM, Swash M, Alberman E, Day SJ. Diagnosis of motor neuron disease by neurologists: a study in three countries. J Neurol Neurosurg Psychiatry 1991; 54: 980-83.
29. Charcot JM. Lectures on the diseases of the nervous system (trans. G Sigerson). London: The New Sydenham Society, 1881.
30. Wechsler IS, Brock S, Weil A. Amyotrophic lateral sclerosis with objective and subjective (neuritic) sensory disturbances. Arch Neurol Psychiatry 1929; 21: 299-310.
31. Li TM, Alberman E, Swash M. Comparison of sporadic and familial disease amongst 580 cases of motor neuron disease J Neurol Neurosurg Psychiatry 1988; 51: 778-84.
32. Elian M. Olfactory impairment in motor neuron disease: a pilot study. J Neurol Neurosurg Psychiatry 1991; 54: 927-28.
33. Dyck PJ, Stevens JC, Mulder DW, Espinosa RE. Frequency of nerve fibre degeneration of peripheral motor and sensory neurons in amyotrophic lateral sclerosis. Neurology 1975; 25: 781-85.
34. Mulder DW, Bushek W, Spring E, Karnes J, Dyck PJ. Motor neuron disease (ALS): evaluation of detection thresholds of cutaneous sensation. Neurology 1983; 33: 1625-27.
35. Jamal G, Wier A, Hansen S, Ballentyne JP. Sensory involvement in motor neurone disease: further evidence from automated threshold determination. J Neurol Neurosurg Psychiatry 1985; 48: 906-10.
36. Dalakas M, DiChiro G, Hatazawa J, Brooks R. The metabolic status of upper motor neurons in patients with ALS and other motor neuron diseases: a study with positron emission tomography (PET) [Abstract]. Muscle Nerve 1986; 9: 100.
37. Abe K, Fujimura H, Toyooka K et al. Single-photon emission computed tomographic investigation of patients with motor neuron disease. Neurology 1993; 43: 1569-73.
38. Tyler HR. Nonfamilial amyotrophy with dementia or multisystem degeneration and other neurological disorders. In: Rowland LP ed. Human motor neuron diseases. New York: Raven Press, 1982.
39. David A, Gillham RA. Neuropsychological study of motor neuron disease. Psychosomatics 1986; 27: 441-45.
40. Milner B. Effects of different brain-lesions on card-sorting; the role of the frontal lobes. Arch Neurol 1963; 9: 100-110.
41. Gallassi R, Montagna P, Ciardalli C, Lorusso S, Moosutu V, Stracchari A. Cognitive impairment in motor neurone disease. Acta Neurol Scand 1985; 71: 480-84.
42. Iwasaki Y, Kinoshita M, Takamiya K, Shiojima T. Cognitive impairment in amyotrophic lateral sclerosis and its relation to motor disabilities. Acta Neurol Scand 1990; 81: 141-43.
43. Capitani E, Della Sala S, Marchetti C. Is there a cognitive impairment in MND? A survey with longitudinal data. Schweiz Arch Neurol Psychiatr 1994; 145: 11-13.
44. Poloni M, Capitani E, Mazzini A, Ceroni M. Neuropsychological measures in amyotrophic lateral sclerosis and their relationship with CT scan-assessed cerebral atrophy. Acta Neurol Scand 1986; 74: 257-60.
45. Gallassi R, Montagna P, Morreale A et al. Neuropsychological, electroencephalogram and brain computed tomography findings in motor neurone disease. Eur Neurol 1989; 29: 115-20.
46. Neary D, Snowden J, Mann D, Northern B, Goulding P, Macdermott N. Frontal lobe dementia and motor neuron disease. J Neurol Neurosurg Psychiatry 1990; 53: 23-32.
47. King HE. Intellectual function. In: Mettler FA ed. Selective partial ablation of the frontal cortex. New York: Hoeber Inc., 1949: 178-207.
48. Atwell CR. Psychometric changes following lobotomy. In: Ashburg A, McKhann G, McDonald W eds. Studies in lobotomy. London: Heinemann, 1951: 428-35.
49. Wikstrom J, Paetau A, Palo J, Sulkava R, Haltia M. Classical amyotrophic lateral sclerosis with dementia. Arch Neurol 1982; 39: 681-83.
50. Calne DB, Eisen A. The relationship between Alzheimer's disease, Parkinson's disease and motor neuron disease. Can J Neurol Sci 1989; 16: 547-50.
51. Neary D, Snowden J, Mann D, Northern B, Goulding P. Dementia of frontal lobe type. J Neurol Neurosurg Psychiatry 1988; 51: 353-61.
52. Orrell MW, Sahakian BJ. Dementia of frontal lobe type. Psychol Med 1991; 21: 553-56.
53. Deymeer F, Smith TW, DeGirolani U, Drachman DA. Thalamic dementia and motor neuron disease. Neurology 1989; 38: 58-61.
54. Mann DM, South PW. The topographical distribution of brain atrophy in frontal lobe dementia. Acta Neuropathol 1993; 85: 334-40.
55. Horoupian DS, Thal L, Katzman R et al. Dementia and motor neuron disease: morphometric, biochemical and Golgi studies. Ann Neurol 1984; 16: 305-13.
56. Sawada H, Udaka F, Kishi Y et al. Single photon emission computed tomography in motor neuron disease with dementia. Neuroradiology 1988; 30: 577-78.
57. Ferrer I, Roig C, Espino A, Peiro G, Guiu XM. Dementia of frontal lobe type and motor neuron disease. A Golgi study of the frontal cortex. J Neurol Neurosurg Psychiatry 1991; 54: 932-34.
58. Mitsuyama U, Takamiya S. Presenile dementia with motor neuron disease in Japan. A new entity? Ann Neurol 1979; 26: 269-74.
59. Marin-Padilla M. Neurons of layer I. A developmental analysis. In: Peters A, Jones EG. Cerebral cortex, Volume 1. Cellular components of the cerebral cortex. New York: Plenum Press, 1984: 447-78.
60. White EL. Cortical circuits: synoptic organization of the cerebral cortex, structure function and theory. Boston: Birkhauser, 1989.
61. Wightman G, Mann D, Neary D, Swash N, Anderton BH, Leigh PN. New features of cortical involvement in amyotrophic lateral sclerosis (ALS) [Abstract]. J Neurol 1992; 239(suppl 2): S101.
62. Ferrer I. Dementia of frontal lobe type and amyotrophy. Behav Neurol 1992; 5: 87-96.
63. Kiernan JA Hudson AJ. Frontal lobe atrophy in motor neuron diseases. Brain 1994; 117: 747-57.
64. Hudson AJ. Amyotrophic lateral sclerosis and its association with dementia, Parkinsonism and other neurological disorders: a review. Brain 1981; 104: 217-27.
65. Kusaka H, Imai T. Pathology of motor neurons in amyotrophic lateral sclerosis with dementia. Clin Neuropathol 1993; 12: 164-68.
66. Talbot PR, Goulding PJ, Lloyd JJ, Snowden JS, Neary D, Testa HJ. Inter-relation between 'classic' motor neuron disease and frontotemporal dementia: a neuropsychological and single photon emission computed tomography study. J Neurol Neurosurg Psychiatry 1995; 58: 541-17.
67. Kew JJM, Leigh PN, Playford ED et al. Cortical function in amyotrophic lateral sclerosis: a positron emission tomography study. Brain 1993; 116: 655-80.
68. Kew JJM, Goldstein LH, Leigh PN et al. The relationship between abnormalities of cognitive function and cerebral activation in amyotrophic lateral sclerosis: a neuropsychological and positron emission tomography study. Brain 1993; 116: 1399-423.
69. Swash M, Ingram DA. Preclinical and subclinical events in motor neurone disease. J Neurol Neurosurg Psychiatry 1987; 51: 165-68.
70. Cavanagh JB. Morphological problems posed by 'motor neurone disease'. In: Rose FC ed. Motor neurone disease. Tunbridge Wells: Pitman, 1977.
71. Pallis CA. Motor neurone disease: two awkward questions. In: Rose FC ed. Motor neurone disease. Tunbridge Wells: Pitman, 1977.
72. Frank AO, Maguire GP eds. Disabling diseases. Oxford: Heinemann, 1988.
73. Nichols KA. Psychological care in physical illness. Second edition. London: Chapman & Hall, 1993.
74. Horta E. Emotional response to amyotrophic lateral sclerosis and its impact on management of patient care. In: Caroscio JT ed. Amyotrophic lateral sclerosis: a guide 10 patient care. New York: Thieme Medical, 1986: 282-89.
75. Brown WA, Mueller PS. Psychological function in individuals with amyotrophic lateral sclerosis (ALS). Psychosom Med 1970; 32: 141-52.
76. Rosin AJ. The problems of motor neurone disease. Age Ageing 1976; 5; 37-42.
77. Peters PK, Swenson WM, Mulder DW. Is there a characteristic personality profile in amyotrophic lateral sclerosis? An MMPI study. Arch Neurol 1978; 35: 321-22.
78. Schiffer RB, Babigian HM. Behavioural disorders in multiple sclerosis, temporal lobe epilepsy and amyotrophic lateral sclerosis: an epidemiological study. Arch Neurol 1984; 41: 1067-69.
79. Bocker FM, Seibold I, Neundorfer B. Disability in everyday tasks and subjective status of patients with advanced amyotrophic lateral sclerosis. Fortschr Neurol Psychiatr 1990; 58: 224-36.
80. Gould BS, Houpt JL, Norris FH. Psychological characteristics of patients with amyotrophic lateral sclerosis (ALS). Psychosom Med 1977; 39: 299-303.
81. Montgomery GK, Erikson LM. Neuropsychological perspectives in amyotrophic lateral sclerosis. In: Brooks BR ed. Neurologic clinics, Volume 5. Philadelphia, PA: WB Saunders, 1987: 61-81.
82. Hogg KE, Goldstein LH, Leigh PN. The psychological impact of motor neurone disease. Psychol Med 1994; 24: 625-32.
83. Hunter MD, Robinson IC, Neilson S. The functional and psychological status of patients with amyotrophic lateral sclerosis: some implications for rehabilitation. Disabil Rehabil 1993; 15: 119-26.
84. Rosenberg M. Society and the adolescent self-image. New York: Princeton University Press, 1967.
85. Bergner M, Bobbitt RA, Pollard WE, Martin DP, Gilson BS. The Sickness Impact Profile: validation of a health status measure. Med Care 1976; 14: 57-67.
86. Hillel AD, Miller RM, Yorkston K, McDonald E, Norris FH, Konikow N. Amyotrophic lateral sclerosis severity scale. In: Amyotrophic lateral sclerosis. Rose FC ed. New York: Demos Publications, 1990: 93-97.
87. Silverstein MD, Stocking CB, Antel JP. Amyotrophic lateral sclerosis and life-sustaining therapy; patients' desires for information, participation in decision-making, and life-sustaining therapy. Mayo Clin Proc 1991; 66: 906-13.
88. Beisecker AE, Cobb AK, Zeigler DK. Patients' perspectives of the role of care providers in amyotrophic lateral sclerosis. Arch Neurol 1988; 45: 553-56.
89. Rose FC. The management of motor neurone disease. In: Cosi V, Kato AC, Parlettes W et al. eds. Amyotrophic lateral sclerosis: therapeutic, psychological and research issues. New York: Plenum, 1987: 167-74.
90. Williams JM, Klein K, Little M, Haban G. Family observations of everyday cognitive impairment in dementia. Arch Clin Neuropsychol 1986; 1: 103-109.
91. Rao SM ed. Neurobehavioural aspects of multiple sclerosis. New York: Oxford University Press, 1990.
92. Stuss DT. Disturbances of self-awareness after frontal system damage. In: Prigatano GP, Schacter DL eds. Awareness of deficit after brain injury. New York: Oxford University Press, 1991: 63-83.
93. Hall JN. Towards a psychology of caring. Br J Clin Psychol 1990; 29: 129-44.
94. Croyle RT, Berger SD. Illness cognition. In: Maes S, Leventhal H, Johnston M eds. International Review of Health Psychology, Volume 2. Chichester: Wiley, 1993: 29-49.
95. Newman S, Shipley M eds. Psychological aspects of rheumatic disease. London: Baillière Tindall, 1993.
96. Lau RR, Bernard TM, Hartman KA. Further explorations of common-sense representations of common illnesses. Health Psychol 1989; 8: 195-219.
97. Leventhal H, Diefenbach M, Leventhal E. Illness cognition: using common sense to understand treatment adherence and affect cognition interactions. Cogn Ther Res 1992; 16: 143-63.
98. Johnston M, Marteau T, Partridge C, Gilbert P. Changes in patient perceptions of chronic disease and disability with time. In: Schmidt LR, Schwenkmezgar P, Weinman J, Maes S eds. Theoretical and applied aspects of health psychology. Chur: Harwood Academic, 1993: 361-71.
99. Ginsberg N. Living and coping with amyotrophic lateral sclerosis: the psychosocial impact. In: Caroscio JT ed. Amyotrophic lateral sclerosis: a guide to patient care. New York: Thieme Medical, 1986: 273-80.
100. Tyerman AD, Hobbs L, Measures AC. Quality of life in family members of persons with chronic neurological disability. In: Trimble MR, Dodson WE eds. Epilepsy and quality of life. New York: Raven Press, 1994: 33-48.
101. Hornsey J. Empowering patient and carer through terminal MND. Nurs Times 1994; 90(29): 37-39.
102. Moore MK. Dying at home: a way of maintaining control for the person with ALS/MND. Palliat Med 1993; 7: 65-68.
103. Hicks F, Corcoran G. Should hospices offer respite care to patients with motor neurone disease? Palliat Med 1993; 7: 145-50.
104. Newrick PG, Langton-Hewer R. Motor neurone disease: can we do better? A study of 42 patients. BMJ 1984; 289: 539-42.
105. Way J, Steiner TJ. Motor neurone disease: what can the GP do? Practitioner 1986; 230: 149-53.
106. Elliot FA. Clinical neurol, seventh edition. Philadelphia, PA: WB Saunders, 1971.
107. Gilroy J, Stirling-Meyer J. Medical neurology, third edition. New York: Macmillan, 1979.
108. Campbell MJ. Management of patients with motor neurone disease. Int Rehabil Med 1980; 2: 111-15.
109. Munsat TL. Adult motor neurone diseases. In: Rowland LP ed. Merritt's textbook of neurology, seventh edition. Philadelphia, Lee and Febiger, 1984: 548-52.
110. Thomas S. Motor neurone disease: a progressive disease requiring a co-ordinated approach. Profess Nurse 1993; 8: 583-85.
111. Oxtoby M, Eikaas M. Multidisciplinary management from day one: the neuro-care approach to motor neurone disease. Palliat Med 1993; 7: 31-36.
112. Lange DJ, Murphy PL, Maxfield RA. Skarvala A-M, Riedel G. Management of patients with amyotrophic lateral sclerosis. J Neurol Rehabil 1994; 8: 75-82.